ELAN
Price
$23.55
Change
+$0.01 (+0.04%)
Updated
Oct 16 closing price
Capitalization
11.22B
20 days until earnings call
Intraday BUY SELL Signals
XPH
Price
$61.84
Change
-$1.18 (-1.87%)
Updated
Oct 16 closing price
Net Assets
444.12M
Intraday BUY SELL Signals
Interact to see
Advertisement

ELAN vs XPH

ELAN vs XPH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ELAN vs. XPH commentary
Oct 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and XPH is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ELAN with price predictions
Oct 16, 2026

ELAN's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ELAN turned positive on October 05, 2026. Looking at past instances where ELAN's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on ELAN as a result. In 50 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.

ELAN moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELAN advanced for three days, in 172 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for ELAN moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

ELAN broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ELAN entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. ELAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.703) is normal, around the industry mean (43.873). P/E Ratio (374.143) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (4.042) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.275) is also within normal values, averaging (178.797).

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
a Summary for XPH with price predictions
Oct 16, 2026

XPH in -3.03% downward trend, falling for three consecutive days on October 14, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where XPH declined for three days, in 232 of 277 cases, the price declined further within the following month. The odds of a continued downward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for XPH crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for XPH entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where XPH's RSI Indicator exited the oversold zone, 18 of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +2.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where XPH advanced for three days, in 278 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

XPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

FUNDAMENTALS RATINGS
ELAN: Fundamental Ratings
ELAN
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELANXPH
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
80%
COMPARISON
Comparison
Oct 17, 2026
Stock price -- (ELAN: $23.55)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 1 FA rating(s) are green while .

  • ELAN’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 4 TA indicator(s) are bullish.

  • ELAN’s TA Score: 4 bullish, 5 bearish.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а +2.75% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -6.95%. For the same industry, the average monthly price growth was -5.23%, and the average quarterly price growth was +10.96%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-6.95% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
ELAN
Daily Signal:
Gain/Loss:
XPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BADGER.X0.3220780.004271
+1.34%
Badger DAO cryptocurrency
STMX.X0.000003N/A
-0.02%
StormX cryptocurrency
YGG.X0.026045-0.000062
-0.24%
Yield Guild Games cryptocurrency
FIL.X1.156626-0.003932
-0.34%
Filecoin cryptocurrency
ORDI.X3.926353-0.013527
-0.34%
ORDI cryptocurrency

XPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, XPH has been loosely correlated with NUVB. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if XPH jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XPH
1D Price
Change %
XPH100%
-1.87%
NUVB - XPH
46%
Loosely correlated
-6.32%
ELAN - XPH
44%
Loosely correlated
+0.04%
ROIV - XPH
43%
Loosely correlated
-1.50%
ANRO - XPH
42%
Loosely correlated
-3.01%
PLRX - XPH
40%
Loosely correlated
-7.46%
More